| Year |
Citation |
Score |
| 2018 |
Liu J, Gallo RM, Khan MA, Iyer AK, Kratzke IM, Brutkiewicz RR. JNK2 modulates the CD1d-dependent and -independent activation of iNKT cells. European Journal of Immunology. PMID 30467836 DOI: 10.1002/Eji.201847755 |
0.335 |
|
| 2015 |
Iyer AK, Liu J, Gallo RM, Kaplan MH, Brutkiewicz RR. STAT3 promotes CD1d-mediated lipid antigen presentation by regulating a critical gene in glycosphingolipid biosynthesis. Immunology. 146: 444-55. PMID 26260288 DOI: 10.1111/Imm.12521 |
0.333 |
|
| 2013 |
Gallo RM, Bryant IN, Mill CP, Kaverman S, Riese DJ. Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant. Journal of Cancer Research and Therapeutic Oncology. 1: 10. PMID 24791013 DOI: 10.17303/Jcrto.2013.1.104 |
0.817 |
|
| 2012 |
Gallo RM, Khan MA, Shi J, Kapur R, Wei L, Bailey JC, Liu J, Brutkiewicz RR. Regulation of the actin cytoskeleton by Rho kinase controls antigen presentation by CD1d. Journal of Immunology (Baltimore, Md. : 1950). 189: 1689-98. PMID 22798677 DOI: 10.4049/Jimmunol.1101484 |
0.39 |
|
| 2012 |
Wilson KJ, Mill C, Lambert S, Buchman J, Wilson TR, Hernandez-Gordillo V, Gallo RM, Ades LM, Settleman J, Riese DJ. EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling. Growth Factors (Chur, Switzerland). 30: 107-16. PMID 22260327 DOI: 10.3109/08977194.2011.649918 |
0.801 |
|
| 2012 |
Wilson KJ, Mill CP, Gallo RM, Cameron EM, VanBrocklin H, Settleman J, Riese DJ. The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist. The Biochemical Journal. 443: 133-44. PMID 22216880 DOI: 10.1042/Bj20110921 |
0.803 |
|
| 2010 |
Khan MA, Gallo RM, Brutkiewicz RR. Anthrax lethal toxin impairs CD1d-mediated antigen presentation by targeting the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway. Infection and Immunity. 78: 1859-63. PMID 20194602 DOI: 10.1128/Iai.01307-09 |
0.429 |
|
| 2007 |
Gallo RM, Riese DJ. The antibody sc-33040-R fails to specifically recognize phosphorylation of ErbB4 on tyrosine1056. Growth Factors (Chur, Switzerland). 25: 329-33. PMID 18236211 DOI: 10.1080/08977190701804008 |
0.717 |
|
| 2007 |
Riese DJ, Gallo RM, Settleman J. Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 29: 558-65. PMID 17508401 DOI: 10.1002/Bies.20582 |
0.791 |
|
| 2006 |
Gallo RM, Bryant I, Fry R, Williams EE, Riese DJ. Phosphorylation of ErbB4 on Tyr1056 is critical for inhibition of colony formation by prostate tumor cell lines. Biochemical and Biophysical Research Communications. 349: 372-82. PMID 16934755 DOI: 10.1016/J.Bbrc.2006.08.055 |
0.78 |
|
| 2006 |
Gilmore JL, Gallo RM, Riese DJ. The epidermal growth factor receptor (EGFR)-S442F mutant displays increased affinity for neuregulin-2beta and agonist-independent coupling with downstream signalling events. The Biochemical Journal. 396: 79-88. PMID 16445385 DOI: 10.1042/Bj20051687 |
0.788 |
|
| 2005 |
Hobbs SS, Gallo RM, Riese DJ. Phe45 of NRG2beta is critical for the affinity of NRG2beta for ErbB4 and for potent stimulation of ErbB4 signaling by NRG2beta*. Growth Factors (Chur, Switzerland). 23: 273-83. PMID 16338790 DOI: 10.1080/08977190500199345 |
0.8 |
|
| 2004 |
Hobbs SS, Cameron EM, Hammer RP, Le AT, Gallo RM, Blommel EN, Coffing SL, Chang H, Riese DJ. Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinase. Oncogene. 23: 883-93. PMID 14661053 DOI: 10.1038/Sj.Onc.1207250 |
0.816 |
|
| 2003 |
Williams EE, Trout LJ, Gallo RM, Pitfield SE, Bryant I, Penington DJ, Riese DJ. A constitutively active ErbB4 mutant inhibits drug-resistant colony formation by the DU-145 and PC-3 human prostate tumor cell lines. Cancer Letters. 192: 67-74. PMID 12637154 DOI: 10.1016/S0304-3835(02)00690-0 |
0.595 |
|
| Show low-probability matches. |